Re: Asia, Australia and New Zealand Dyspnoea in Emergency Departments (AANZDEM) study: Rationale, design and analysis: Letters to the Editor

Currow, David C.; Hutchinson, Ann; Johnson, Miriam J.

doi:10.1111/1742-6723.12429

High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction (2023)
Journal Article
Boland, J. W., Boland, E. G., & Currow, D. C. (2023). High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 31(4), Article 211. https://doi.org/10.1007/s00520-023-07669-8

Invisibility of breathlessness in clinical consultations: a cross-sectional, national online survey (2022)
Journal Article
Kochovska, S., Chang, S., Ferreira, D., Brunelli, V. N., Luckett, T., Morgan, L., …Currow, D. C. (2022). Invisibility of breathlessness in clinical consultations: a cross-sectional, national online survey. European respiratory journal, 60(5), Article 2201603. https://doi.org/10.1183/13993003.01603-2022

Breathlessness diminishes the physical, mental and social wellbeing of people living long-term with this disabling symptom [1]. Identifying its impacts on patients and their families helps to inform appropriate non-pharmacological and pharmacological... Read More about Invisibility of breathlessness in clinical consultations: a cross-sectional, national online survey.

Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study (2020)
Journal Article
Ekström, M., Bornefalk, H., Sköld, C. M., Janson, C., Blomberg, A., Sandberg, J., …Sundh, J. (2021). Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study. European respiratory journal, 57(3), https://doi.org/10.1183/13993003.02823-2020

Chronic breathlessness is a dominating symptom that restricts daily life for many people with cardiorespiratory disease [1]. Different dimensions of the symptom, such as the intensity, sensory qualities (SQs) and emotional responses, can be assessed... Read More about Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study.

Letter in Response to Grobler AC, Lee K. Intention-To-Treat Analyses for Randomized Controlled Trials in Hospice/Palliative Care Enhanced by Principled Methods to Handle Missing Data (2020)
Journal Article
Huang, C., Kochovska, S., & Currow, D. C. (2020). Letter in Response to Grobler AC, Lee K. Intention-To-Treat Analyses for Randomized Controlled Trials in Hospice/Palliative Care Enhanced by Principled Methods to Handle Missing Data. Journal of pain and symptom management, 60(4), e30-e31. https://doi.org/10.1016/j.jpainsymman.2020.07.004

Low agreement between mMRC rated by patients and clinicians: Implications for practice (2019)
Journal Article
Ekstrom, M., Chang, S., Johnson, M. J., Fazekas, B., Kochovska, S., Huang, C., & Currow, D. C. (2019). Low agreement between mMRC rated by patients and clinicians: Implications for practice. European respiratory journal, 54(6), Article 1901517. https://doi.org/10.1183/13993003.01517-2019

Acute-on-chronic breathlessness: recognition and response (2019)
Journal Article
Hutchinson, A., Johnson, M. J., & Currow, D. (2019). Acute-on-chronic breathlessness: recognition and response. Journal of pain and symptom management, 57(5), e4-e5. https://doi.org/10.1016/j.jpainsymman.2019.01.012

Statistical compared to clinical significance and the risk of misattribution (2018)
Journal Article
Ekström, M., Johnson, M. J., & Currow, D. C. (2018). Statistical compared to clinical significance and the risk of misattribution. European respiratory journal, 52(5), Article 1801723. https://doi.org/10.1183/13993003.01723-2018

Response to “Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later” (2018)
Journal Article
Boland, J. W., Johnson, M., & Currow, D. (2019). Response to “Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later”. Journal of pain and symptom management, 57(3), e12-e13. https://doi.org/10.1016/j.jpainsymman.2018.11.018

Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial (2018)
Journal Article
Ahmadi, Z., Sandberg, J., Shannon-Honson, A., Vandersman, Z., Currow, D. C., & Ekström, M. (2018). Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial. European respiratory journal, 52(3), Article 1800887. https://doi.org/10.1183/13993003.00887-2018

The strength of evidence: low dose morphine for chronic breathlessness (2018)
Journal Article
Currow, D. C., Ekström, M., & Johnson, M. J. (2018). The strength of evidence: low dose morphine for chronic breathlessness. Internal Medicine Journal, 48(1), 102-103. https://doi.org/10.1111/imj.13660

One evidence base; three stories: do opioids relieve chronic breathlessness? (2017)
Journal Article
Ekstrom, M., Currow, D. C., Johnson, M. J., Ekström, M., Bajwah, S., Bland, J. M., …Johnson, M. (2018). One evidence base; three stories: do opioids relieve chronic breathlessness?. Thorax, 73(1), 88-90. https://doi.org/10.1136/thoraxjnl-2016-209868

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. The efficacy of low-dose systemic opioids for chronic br... Read More about One evidence base; three stories: do opioids relieve chronic breathlessness?.

The independent association of overweight and obesity with breathlessness in adults: a cross-sectional, population-based study (2017)
Journal Article
Currow, D. C., Dal Grande, E., Sidhu, C., Ekström, M., & Johnson, M. J. (2017). The independent association of overweight and obesity with breathlessness in adults: a cross-sectional, population-based study. European respiratory journal, 50(3), Article 1700558. https://doi.org/10.1183/13993003.00558-2017

Obesity is an independent risk factor for chronic breathlessness and should be assessed in people with this symptom.

Invisible suffering : breathlessness in and beyond the clinic—a reply (2015)
Journal Article
Hutchinson, A., Booth, S., Currow, D., Higginson, I., & Johnson, M. (2015). Invisible suffering : breathlessness in and beyond the clinic—a reply. The lancet. Respiratory medicine, 3(8), e29. https://doi.org/10.1016/S2213-2600%2815%2900232-5

Letter

Re: Asia, Australia and New Zealand Dyspnoea in Emergency Departments (AANZDEM) study: Rationale, design and analysis: Letters to the Editor (2015)
Journal Article
Currow, D. C., Hutchinson, A., & Johnson, M. J. (2015). Re: Asia, Australia and New Zealand Dyspnoea in Emergency Departments (AANZDEM) study: Rationale, design and analysis: Letters to the Editor. Emergency medicine Australasia : EMA, 27(5), 498-499. https://doi.org/10.1111/1742-6723.12429

All Outputs (14)